paroxetine has been researched along with Hypertrophy, Left Ventricular in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhuiyan, S; Fukunaga, K; Hasegawa, H; Kanai, H; Shioda, N; Tagashira, H | 1 |
| MacIver, DH; Partridge, SJ; Solanki, T | 1 |
2 other study(ies) available for paroxetine and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
Sigma1-receptor stimulation with fluvoxamine ameliorates transverse aortic constriction-induced myocardial hypertrophy and dysfunction in mice.
Topics: Animals; Aorta; Cells, Cultured; Fluvoxamine; Hypertrophy, Left Ventricular; Male; Mice; Mice, Inbred ICR; Models, Animal; Myocardial Contraction; Myocytes, Cardiac; Nitric Oxide Synthase Type III; Paroxetine; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Receptors, sigma; Selective Serotonin Reuptake Inhibitors; Sigma-1 Receptor; Time Factors; Vasoconstriction; Ventricular Dysfunction, Left | 2010 |
A depressed myocardium.
Topics: Adult; Anti-Arrhythmia Agents; Cardiomyopathies; Chest Pain; Cyclohexanols; Electrocardiography; Heart; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Tachycardia, Sinus; Venlafaxine Hydrochloride; Ventricular Function, Left | 2000 |